Print page

HALCYGEN PHARMACEUTICALS LIMITED (HGN)

The manufacture and development of super generic drugs

On this page you will find:

Delayed share price		Company details
Company announcements		Closing prices
Price history chart		Dividends
Exchange Traded Options		Warrants & Structured Products
		ASX CFDs

Delayed share price

Prices are delayed by at least 20 minutes. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
HGN	0.550	-1.79%	0.525	0.550	0.560	0.560	0.550	50,177
(Status - CD)

HALCYGEN PHARMACEUTICALS LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	HGN
Securities
Official Listing Date	29 June, 2007
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Registered Office Address	Level 10, 470 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone	(03) 8614 7777
Head Office Fax	(03) 9614 7022
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Dr Roger Aston (Chairman, CEO) The Hon Ron Best (Non Exec. Director) Mr Bruce Mathieson (Non Exec. Director) Mr Ian Scholes (Non Exec. Director) Mr Aaron Finlay (CFO) Ms Lisa Pendlebury (Investor Relations)

Company Secretary	Mr Aaron Finlay
Principal Activities	The manufacture and development of super generic drugs

HALCYGEN PHARMACEUTICALS LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Headline	Pages	PDF
31/08/2010	F10 Financial Results Presentation	19	PDF
31/08/2010	Preliminary Final Report and Maiden Dividend	13	PDF
26/08/2010	Singapore Distribution Agreement Signed	2	PDF
11/08/2010	US Sales of Doryx Update	2	PDF
06/08/2010	Appendix 3B	7	PDF
05/08/2010	Senior Management Appointment	2	PDF
29/07/2010	Appendix 3B	7	PDF
29/07/2010	Amended Final Director`s Interest Notice	2	PDF
29/07/2010	Director resignation and management update	2	PDF
29/07/2010	Final Director`s Interest Notice	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
08 Sep 2010	0.560	-0.88%	0.560	0.550	127,619
07 Sep 2010	0.565	0.89%	0.570	0.560	256,686
06 Sep 2010	0.560	1.82%	0.570	0.560	204,513
03 Sep 2010	0.550	-2.65%	0.570	0.550	771,509
02 Sep 2010	0.565	-0.88%	0.570	0.565	194,400

* Volume of shares shown represents only those shares traded on ASX.

HALCYGEN PHARMACEUTICALS LIMITED price history chart

ASX excludes all liability arising out of any inaccuracies in this chart, except where liability is made non-excludable by legislation. Chart values may be adjusted for changes in a company's capital structure or to link historical values that represent the company's primary equity security. Explanation of chart terms.

Dividends

How are dividends released on www.asx.com.au?

Code	Div Amount	Ex Div Date	Record Date	Date Payable	% Franked	Type	Further Information
HGN	2c	25/10/2010	29/10/2010	18/11/2010	100%	Final	2C FRANKED @ 30%

Exchange Traded Options

No options are available over the security HGN

Warrants & Structured Products

No warrants & Structured Products are available over the security HGN

ASX CFDs

No Contracts For Differences are available over the security HGN

Company information lookup